| Heading: |
Tofersen |
| Question ID: |
1819830 |
| UIN: |
65163 |
| House: |
Commons |
| Date tabled: |
2025-07-04 |
| Asking Member ID: |
5072 |
| Asking Member display name: |
Mr Andrew Snowden
|
| Asking Member handle: |
A_J_Snowden
|
| Asking Member Twitter reference: |
@A_J_Snowden
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of the availability of Tofersen across NHS trusts in England; and what steps he is taking to ensure equitable geographic access. |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2025-07-09 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
4444 |
| Answering Member display name: |
Karin Smyth
|
| Answering Member handle: |
karinsmyth
|
| Answering Member Twitter reference: |
@karinsmyth
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
The National Institute for Health and Care Excellence (NICE) is the independent body responsible for developing authoritative, evidence-based recommendations for the National Health Service on whether new medicines represent a clinically and cost-effectiv... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |